Indication

Immunoglobulin G4-related disease

Immunoglobulin G4-related disease is a chronic, immune-mediated fibroinflammatory condition characterized by tumefactive lesions, tissue swelling, and progressive organ dysfunction that predominantly affects middle-aged and older adults. Read more about Immunoglobulin G4-related disease

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Immunoglobulin G4-related disease therapies.

Showing 1–2 of 2 drugs

UPLIZNA (inebilizumab-cdon)

ANTINEOPLASTIC MONOCLONAL ANTIBODIES·NEUROMYELITIS OPTICA SPECTRUM DISORDER WITH ANTI-AQUAPORIN-4 (AQP4) ANTIBODIES·+3
HORIZON/AMGEN
Filter & compare in the drug finder →Opens the drug finder with Immunoglobulin G4-related disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Immunoglobulin G4-related disease.

Immunoglobulin G4-related disease is a chronic, immune-mediated fibroinflammatory condition characterized by tumefactive lesions, tissue swelling, and progressive organ dysfunction that predominantly affects middle-aged and older adults.

While it can involve virtually any anatomical site, it frequently affects the pancreas, salivary and lacrimal glands, retroperitoneum, aorta, and kidneys.

Pathophysiologically, the disease is defined by dense lymphoplasmacytic infiltrates enriched with IgG4-positive plasma cells, storiform fibrosis, obliterative phlebitis, and frequently elevated serum concentrations of immunoglobulin G4.

Untreated, the resultant fibrosing inflammatory process can mimic malignancy and lead to irreversible structural injury and end-organ failure.

Personalize your experience

Follow Immunoglobulin G4-related disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it